Michael Fenn

As Director of External Innovation, Michael helps solve some of the most pressing challenges in the biomolecular condensate field by working closely with the R&D and business development teams to source and evaluate emerging technological and therapeutic assets of strategic interest, as well as efficiently manage the world-class scientific advisory board, and foster collaborations with a variety of current and future partners.